poster

Full-Spectrum Efficacy of Cariprazine on Manic and Depressive Poles of Bipolar I Disorder in Patients Experiencing Manic or Depressive Episodes: Post Hoc Analysis of Randomized Controlled Trial Data

Abstract: Background: Treating patients with bipolar I disorder (BP-I) with an agent that is only effective against one pole may elicit treatment-emergent affective switch (TEAS), or wors...

01/19/2023

Effects of Cariprazine on Reducing Symptoms of Hostility and Agitation in Patients with Manic or Mixed Episodes of Bipolar I Disorder

Abstract: Background: Bipolar mania and mixed episodes can be associated with hostility and agitated behavior. Effects of cariprazine on these symptoms were evaluated in this post hoc ana...

01/19/2023

Early Improvement With Cariprazine as a Predictor of Antidepressant and Anxiolytic Response in Bipolar Depression: Pooled Post Hoc Analysis of 2 Randomized Cariprazine Trials

Abstract: Introduction: Treatment non-response may indicate need for further clinical management; thus, early prediction of treatment response can aid clinical decision-making, including ...

01/19/2023

A Retrospective Real-World Analysis Demonstrating the Value of Azstarys for Patients With Attention-Deficit Hyperactivity Disorder

Abstract: Aim: To quantify the value of Azstarys (serdexmethylphenidate/dexmethylphenidate) for patients with attention-deficit hyperactivity disorder (ADHD) with real-world data from the...

01/19/2023

Prioritizing Treatment Goals of Patients Diagnosed with Bipolar I Disorder: Results from a US Patient Survey Using Best-Worst Scaling

Abstract: Background Bipolar I disorder (BP-I) patients often have numerous unmet needs. There exists a paucity of evidence on the goals of patients diagnosed with BP-I that could help gu...

01/19/2023

Serdexmethylphenidate/Dexmethylphenidate for Children With Attention-Deficit Hyperactivity Disorder: Reduction in Disorder Severity From a Laboratory Classroom Study

Abstract: Aim: To evaluate changes in attention-deficit hyperactivity disorder (ADHD) severity in children (aged 6-12 years) posttreatment with serdexmethylphenidate/dexmethylphenidate (S...

01/19/2023

Dosing Intervals and Cost Per Day of Aripiprazole Once-Monthly 400 mg and Aripiprazole Lauroxil 882 mg in the Treatment of Patients With Schizophrenia or Bipolar I Disorder

Abstract: This model examined annual drug treatment costs for aripiprazole once-monthly (AOM) 400 mg and aripiprazole lauroxil (AL) 882 mg among adult patients with schizophrenia or bipol...

01/19/2023

Cost-Effectiveness of Aripiprazole 2-Month Ready-to-Use 960 mg Long-Acting Injectable for the Treatment of Patients With Schizophrenia

Abstract: Background: Aripiprazole 2-month Ready to Use 960 mg (ARI 2M RTU) is a long-acting injectable antipsychotic (LAI) in development for treatment of schizophrenia and maintenance t...

01/19/2023

Seltorexant Reduces Core Depressive Symptoms in Patients With Major Depressive Disorder: Analysis Based on MADRS-WOSI and MADRS-6

Abstract: Objectives: To evaluate seltorexant effect in improving depressive symptoms beyond sleep-related improvement in major depressive disorder (MDD) using MADRS-WOSI (MADRS without s...

01/19/2023

Efficacy and Safety of Brexpiprazole for the Treatment of Borderline Personality Disorder: a 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Abstract: Background: Atypical antipsychotics may be efficacious in the treatment of borderline personality disorder (BPD). This double-blind, Phase 2 study (NCT04100096) evaluated the ef...

01/19/2023

Tracks

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products